Lung Competitors

Stocks . Taiwan . 
Stock . Lung Ming Green
3018 Stock   11.90  0.10  0.85%   
Lung Ming Green competes with Chang Jia, Sun Sea, Chien Wei, Jian Sin, and Inalways; as well as few others. Analyzing Lung Ming competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Lung Ming to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Lung Ming Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Lung Ming competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
10.5811.9013.22
Details
Intrinsic
Valuation
LowRealHigh
10.8112.1213.45
Details

Lung Ming Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Lung Ming and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Lung and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Lung Ming Green does not affect the price movement of the other competitor.

High positive correlations

4502
+ 0.77
8092
5488
+ 0.65
7715
5488
+ 0.61
4502
7715
+ 0.59
5516
7715
+ 0.54
4550
5547
+ 0.51
4550
  

High negative correlations

5398
- 0.82
4502
5398
- 0.59
5488
5398
- 0.59
8092
4502
- 0.57
5547
8092
- 0.56
5547
5398
- 0.48
5516

Risk-Adjusted Indicators

There is a big difference between Lung Stock performing well and Lung Ming Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lung Ming's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
4550  0.60  0.05 (0.05) 0.77  0.69 
(0.73)
 1.38 
(1.02)
 7.09 
5547  1.15  0.27  0.12  0.97  1.17 
(1.42)
 2.80 
(2.04)
 8.57 
5516  1.81  0.26  0.07 (3.66) 1.86 
(2.48)
 6.38 
(4.18)
 14.02 
7715  1.66  0.29  0.07 (0.40) 1.58 
(2.06)
 4.73 
(3.53)
 8.65 
8092  1.65 (0.09) 0.00  1.43  0.00 
 0.00 
 3.74 
(3.45)
 13.65 
4502  0.51 (0.06) 0.00  4.71  0.00 
 0.00 
 0.96 
(0.94)
 4.35 
5488  0.74 (0.04) 0.00 (0.24) 0.00 
 0.00 
 1.87 
(1.25)
 5.13 
6971  0.99 (0.12) 0.00  0.53  0.00 
 0.00 
 2.42 
(1.93)
 5.05 
4589  0.77  0.00  0.00  0.10  0.00 
 0.00 
 2.62 
(1.99)
 9.15 
5398  2.04  0.28  0.04 (0.43) 2.42 
(2.49)
 6.34 
(5.11)
 17.21 
All Fundamental Data

Lung Ming Competitive Analysis

The better you understand Lung Ming competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Lung Ming's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Lung Ming's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
3018 4550 5547 5516 7715 8092 4502 5488 6971 4589
 0.85 
 11.90 
Lung
 0.78 
 26.00 
Chang
 1.81 
 28.10 
Jioushun
 0.31 
 16.10 
Sun
 4.75 
 38.10 
7715
 3.00 
 14.55 
Chien
 1.89 
 16.15 
Jian
 0.60 
 9.98 
Sunf
 2.52 
 31.00 
6971
 0.28 
 35.25 
Motion
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Somewhat reliable
Very steady
Not too volatile
Very steady
Not too volatile
Very steady
Very steady
Market Performance
(90 Days Performance)
Weakest
Mild
Solid
Mild
Fair
Weakest
Weakest
Weakest
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Small
Low
Unknown
Low
Unknown
Average
Moderate
Fair
Unknown
Unknown
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Strong Hold
Strong Sell
Strong Sell
Strong Hold
Strong Hold
Strong Sell
Strong Sell
Strong Sell
Current Ratio
1.67
1.4
1.25
1.33
N/A
N/A
Net Asset
1.52 B
1.88 B
2.81 B
794.21 M
2.4 B
N/A
Profit Margin
-0.17
0.0735
0.0591
0.0058
-0.0239
N/A
EBITDA
(148.9 M)
157.82 M
180.58 M
16.13 M
22.41 M
N/A
Operating Margin
-0.0931
0.0617
0.095
0.0118
-0.0085
N/A
Current Valuation
929.64 M
677.57 M
1.76 B
783.19 M
3.47 B
N/A
Price To Book
1.59
1.06
1.03
1.7
3.17
N/A
Retained Earnings
(7 M)
N/A
N/A
N/A
N/A
N/A
Current Asset
1.09 B
N/A
N/A
N/A
N/A
N/A
Five Year Return
N/A
7.0
N/A
N/A
N/A
N/A
Beta
0.54
0.28
0.0131
0.59
0.53
N/A
Number Of Employees
11
12
190
7
13
8
Shares Outstanding
78.15 M
37.84 M
45.49 M
38.95 M
57.47 M
N/A
Cash Flow From Operations
(166.16 M)
9.19 M
(193.47 M)
4.85 M
(171.06 M)
N/A
Annual Yield
N/A
0.0462
0.0208
N/A
0.0047
N/A
Total Debt
386.24 M
36.38 M
1.45 B
102.9 M
897.45 M
N/A
Return On Equity
-0.62
0.12
0.2
0.008
-0.0624
N/A
Z Score
1.6
15.6
N/A
2.4
1.2
N/A
Return On Asset
-0.0595
0.03
0.0591
0.0038
-0.0031
N/A
Book Value Per Share
4.64
22.65
17.21
7.66
11.68
N/A
Current Liabilities
562 M
N/A
N/A
N/A
N/A
N/A
Total Asset
1.52 B
1.88 B
2.81 B
794.21 M
2.4 B
N/A
Debt To Equity
57.2
4.7
1.96
92.3
N/A
N/A
Last Dividend Paid
N/A
1.15
0.46
N/A
N/A
1.35
Market Capitalization
576.73 M
953.54 M
1.09 B
467.41 M
2.13 B
767.49 M
Price To Earning
3.79
8.26
5.56
N/A
N/A
N/A
Price To Sales
0.37
0.65
0.32
1.21
1.47
N/A
Net Income
(305.98 M)
53.5 M
120.48 M
(22.48 M)
(145.47 M)
N/A
Earnings Per Share
-3.64
2.68
3.19
0.06
-2.24
N/A
Shares Owned By Insiders
29.59
55.55
67.52
54.15
59.55
N/A
Revenue
1.62 B
1.42 B
2.26 B
343.96 M
1.43 B
N/A
Working Capital
531 M
N/A
N/A
N/A
N/A
N/A
Cash And Equivalents
176.4 M
379.56 M
145.92 M
7.66 M
N/A
N/A
Cash Per Share
2.91
10.37
3.21
0.2
N/A
N/A
Gross Profit
54.41 M
134.59 M
232.8 M
36.23 M
89.48 M
N/A
Day Typical Price
11.87
26.02
27.87
16.12
39.93
14.72
16.05
10.03
31.03
35.15
Accumulation Distribution
125.29
641.97
18065.96
15132.46
601860.0
11553.92
100.4
10588.16
5524.58
77.62
Market Facilitation Index
0.0
0.0
0.0
0.0
0.0
0.0
1.0E-4
0.0
0.0
0.0
Daily Balance Of Power
1.0
0.4444
0.4545
0.04
(0.30)
(0.45)
1.0
0.2069
(0.73)
0.3333
Period Momentum Indicator
0.1
0.2
0.5
0.05
(1.90)
(0.45)
0.3
0.06
(0.80)
0.1
Rate Of Daily Change
1.01
1.01
1.02
1.0
0.95
0.97
1.02
1.01
0.97
1.0
Day Median Price
11.85
26.03
27.75
16.13
40.85
14.8
16.0
10.06
31.05
35.1
Price Action Indicator
0.1
0.075
0.6
N/A
(3.70)
(0.47)
0.3
(0.04)
(0.45)
0.2
Coefficient Of Variation
(625.58)
1372.31
503.8
1042.19
1115.25
(3,100)
(1,445)
(5,138)
(1,112)
(43,808)
Mean Deviation
0.7178
0.5998
1.15
1.81
1.66
1.65
0.509
0.7424
0.9918
0.7662
Jensen Alpha
(0.22)
0.0493
0.2685
0.2619
0.2942
(0.09)
(0.06)
(0.04)
(0.12)
(0.0002)
Total Risk Alpha
(0.41)
(0.07)
0.0756
(0.14)
(0.16)
(0.46)
(0.17)
(0.19)
(0.36)
(0.22)
Sortino Ratio
N/A
(0.05)
0.1187
0.0702
0.0718
N/A
N/A
N/A
N/A
N/A
Downside Variance
N/A
0.6825
2.83
4.9
3.61
N/A
N/A
N/A
N/A
N/A
Standard Deviation
1.33
0.9134
1.56
2.76
2.74
2.59
0.741
1.1
1.52
1.44
Kurtosis
15.89
7.01
0.8338
3.58
6.04
5.41
2.59
3.49
6.17
5.57
Potential Upside
1.27
1.38
2.8
6.38
4.73
3.74
0.9554
1.87
2.42
2.62
Treynor Ratio
(9.72)
0.7737
0.9702
(3.66)
(0.40)
1.43
4.71
(0.24)
0.5343
0.1008
Maximum Drawdown
9.89
7.09
8.57
14.02
8.65
13.65
4.35
5.13
5.05
9.15
Variance
1.77
0.8343
2.43
7.63
7.52
6.7
0.5491
1.2
2.31
2.07
Market Risk Adjusted Performance
(9.71)
0.7837
0.9802
(3.65)
(0.39)
1.44
4.72
(0.23)
0.5443
0.1108
Risk Adjusted Performance
(0.11)
0.0529
0.1432
0.074
0.0696
(0.02)
(0.05)
(0.01)
(0.06)
0.0036
Skewness
3.19
1.13
0.2556
1.32
2.02
1.03
(0.25)
1.4
1.97
0.3445
Semi Deviation
N/A
0.691
1.17
1.86
1.58
N/A
N/A
N/A
N/A
N/A
Information Ratio
(0.24)
(0.05)
0.1282
0.0563
0.0497
(0.07)
(0.22)
(0.12)
(0.16)
(0.08)
Value At Risk
(1.83)
(1.02)
(2.04)
(4.18)
(3.53)
(3.45)
(0.94)
(1.25)
(1.93)
(1.99)
Expected Short fall
N/A
(0.73)
(1.42)
(2.48)
(2.06)
N/A
N/A
N/A
N/A
N/A
Downside Deviation
N/A
0.8261
1.68
2.21
1.9
N/A
N/A
N/A
N/A
N/A
Semi Variance
N/A
0.4775
1.36
3.47
2.5
N/A
N/A
N/A
N/A
N/A

Lung Ming Competition Performance Charts

Five steps to successful analysis of Lung Ming Competition

Lung Ming's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Lung Ming Green in relation to its competition. Lung Ming's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Lung Ming in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Lung Ming's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Lung Ming Green, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Lung Ming position

In addition to having Lung Ming in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Sports Thematic Idea Now

Sports
Sports Theme
Companies in sporting activities arena as well as manufacturers of sporting goods and sport retailers. The Sports theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sports Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Lung Stock Analysis

When running Lung Ming's price analysis, check to measure Lung Ming's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lung Ming is operating at the current time. Most of Lung Ming's value examination focuses on studying past and present price action to predict the probability of Lung Ming's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lung Ming's price. Additionally, you may evaluate how the addition of Lung Ming to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY